Rat Alternative Complement Pathway ELISA Kit

The innate immune system is important in the first defense against foreign pathogens. A major
component of this response is the complement system. The complement system consist of a
complex family of proteins and receptors which are found in the circulation, in tissues and other
body-fluids. Nowadays, also several links to the adaptive immunity are described. The system
consist of three defined pathways which are activated by a pathway specific panel of
molecules. Complement activation proceeds in a sequential fashion through the proteolytic
cleavage of a series of proteins leading to the generation of activated products that mediate
various biological activities through their interaction with specific cellular receptors and other
serum proteins The three pathways, designated classical, lectin and alternative pathway,
converge at a central component into a final common pathway. That is activation of C3 leading
to formation of C3a and C3b. This cleavage activates the terminal complement pathway
leading to eventually the formation of the terminal C5b-9 complement complex (TCC). The
classical pathway is initiated by binding of C1q to antibody complexes, whereas the alternative
and lectin pathway are activated in an antibody-independent fashion through the interaction of
complement components with respectively specific carbohydrate groups and
lipopolysaccharides (LPS) on the surface of foreign pathogens. The alternative pathway also
acts as an amplification loop of the other pathways.
Under certain conditions, the complement system can be unfavorable to the host leading to
e.g. autoimmune diseases and infections. Deficiency of C3 is e.g. associated with SLE.
Alterations in the alternative pathway, like properdin or ficolin deficiency, increase the
susceptibility to infection. Mannose binding lectin (MBL), a major component of the lectin
pathway, is associated with bacterial, fungal and viral infection. A common way to measure
the activity of the classical or alternative pathway is the haemolysis of erythrocytes.
Furthermore some assays have been described to measure the activity of the MBL pathway.
Not all assay are easy to perform. The rat pathway ELISAs are easy to use and specific per
pathway by making use of a combination of specialized coatings and buffers. Complement
deficiencies or other defects in the complement system can easily be screened by running an
assay for each pathway in parallel or separately.

This product is manufactured in Netherlands by Hycult Biotech.